Guest guest Posted December 25, 2010 Report Posted December 25, 2010 Blank Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. N Chiorazzi and M Ferrarini Blood, December 9, 2010; The Feinstein Institute for Medical Research, Manhasset, NY; The Departments of Medicine and of Cell Biology, North Shore University Hospital, and Albert Einstein College of Medicine, Manhasset, NY, United States; Several cell types have been suggested as giving rise to chronic lymphocytic leukemia (CLL), and these suggestions have reflected the sophistication of technology available at the time. Although there is no consensus as to the normal cellular counterpart(s) in the disease, an antigen-experienced B lymphocyte appears required based on surface membrane phenotypes and gene expression profiles. However what is still unclear is whether a single or multiple normal precursors were stimulated to evolve into CLL and at what stage(s) this occurred. A unifying, parsimonious theory is that U-CLL and M-CLL derive from marginal zone B cells. However evidence for remarkably similar BCR amino acid sequence and striking differences in poly- and auto-antigen binding activity, found in some but not all CLL clones, challenge a single cell derivation for CLL. In this Perspective, we summarize data regarding normal counterparts of CLL cells and suggest that a multistep process of leukemogenesis is important to consider when assigning a cellular origin for this disease. Finally, although available data do not definitively identify the cell(s) of origin, we offer possibilities for single and multiple cell origin models as straw men that can be improved upon and hopefully lead to final answers to this puzzle. PMID: 21148333 . Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.